Global Information
회사소개 | 문의 | 비교리스트

세계의 바이오의약품 분석 시험 서비스 시장 예측(2020-2024년)

Biopharmaceutical Analytical Testing Services Market 2020-2024

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2020년 01월 상품 코드 672868
페이지 정보 영문 120 Pages
가격
US $ 2,500 ₩ 3,012,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,615,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,820,000 PDF by E-mail (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 6,025,000 PDF by E-mail (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 바이오의약품 분석 시험 서비스 시장 예측(2020-2024년) Biopharmaceutical Analytical Testing Services Market 2020-2024
발행일 : 2020년 01월 페이지 정보 : 영문 120 Pages

세계의 바이오의약품 분석 시험 서비스(Biopharmaceutical Analytical Testing Services) 시장은 예측 기간 중 9%의 CAGR로 성장할 전망이며, 2024년에 11억 8,000만 달러에 달할 것으로 예측되고 있습니다. 이 시장의 성장은 특허 만료 의약품 수의 증가에 의해 촉진되고 있습니다. 또한 분석 시험 서비스의 아웃소싱 증가는 이 시장의 성장을 지원할 것으로 전망됩니다.

세계의 바이오의약품 분석 시험 서비스 시장에 대해 조사했으며, 시장 성장요인, 동향 및 과제, 최종사용자·지역별 시장 분석, 벤더 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

개요

  • 시장 개요

시장 전망

  • 시장 에코시스템
  • 밸류체인 분석

시장 규모

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모 : 2019년
  • 시장 전망 : 2019-2024년 예측

Porter의 산업 분석

  • Five Forces 요약
  • 바이어의 교섭력
  • 공급업체의 교섭력
  • 신규 진출의 위협
  • 대체품의 위협
  • 라이벌의 위협
  • 시장 현황

시장 분석 : 최종사용자별

  • 시장 세분화
  • 비교
  • 제약 및 바이오테크놀러지 기업
  • CRO
  • 시장 기회

고객 상황

  • 개요

시장 분석 : 지역별

  • 세분화
  • 비교
  • 북미
  • 유럽
  • 아시아태평양
  • 남미
  • 중동·아프리카
  • 주요 국가
  • 시장 기회

성장요인, 과제 및 동향

  • 시장 성장요인
  • 거래량 성장요인 : 수요 주도의 성장
  • 거래량 성장요인 : 공급 주도의 성장
  • 거래량 성장요인 : 외부 요인
  • 거래량 성장요인 : 관련 시장에서의 수요 이동
  • 가격 성장요인 : 인플레이션
  • 가격 성장요인 : 저가격으로부터 고가격으로의 이동
  • 시장이 해결해야 할 과제
  • 시장 동향

벤더 구도

  • 개요
  • 벤더 구도
  • 상황 혁신

기업 개요

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • Boston Analytical
  • Catalent Inc.
  • Charles River Laboratories International Inc.
  • Eurofins Scientific
  • Intertek Group PLC
  • Merck KGaA
  • SGS SA
  • Solvias AG
  • STERIS Plc
  • West Pharmaceutical Services Inc.

부록

  • 리포트의 범위
  • 달러의 환율
  • 조사 방법
  • 약어 리스트
KSA 20.03.11

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Global Biopharmaceutical Analytical Testing Services Market 2020-2024

Technavio has been monitoring the global biopharmaceutical analytical testing services market and it is poised to grow by USD 1.18 bn during 2020-2024, progressing at a CAGR of 9% during the forecast period. Our reports on global biopharmaceutical analytical testing services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in number of patent-expired drugs.In addition, increasing outsourcing of analytical testing services is anticipated to boost the growth of the global biopharmaceutical analytical testing services market as well.

Market Segmentation

Technavio's global biopharmaceutical analytical testing services market is segmented as below:

ByEnd-user:

  • Pharma And Biotech Companies
  • CROs

Geographic segmentation

  • North America
  • APAC
  • Europe
  • South America
  • MEA

Key Trends for global biopharmaceutical analytical testing services market growth

This study identifies increasing outsourcing of analytical testing services as the prime reasons driving the global biopharmaceutical analytical testing services market growth during the next few years.

Prominent vendors in global biopharmaceutical analytical testing services market

We provide a detailed analysis of around 25 vendors operating in the global biopharmaceutical analytical testing services market, including some of the vendors such as Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Eurofins Scientific, Intertek Group PLC, Merck KGaA, SGS SA, Solvias AG, STERIS Plc and West Pharmaceutical Services Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End user placement
  • Pharma and biotech companies - Market size and forecast 2019-2024
  • CROs - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Boston Analytical
  • Catalent Inc.
  • Charles River Laboratories International Inc.
  • Eurofins Scientific
  • Intertek Group PLC
  • Merck KGaA
  • SGS SA
  • Solvias AG
  • STERIS Plc
  • West Pharmaceutical Services Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 4
  • 5.Key Finding 5
  • 6.Key Finding 6
  • 7.Key Finding 7
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Product / Service portfolio of key vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ million)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.End user placement - Market share 2019-2024 (%)
  • 23.Comparison by End user placement
  • 24.Pharma and biotech companies - Market size and forecast 2019-2024 ($ million)
  • 25.Pharma and biotech companies - Year-over-year growth 2019-2024 (%)
  • 26.CROs - Market size and forecast 2019-2024 ($ million)
  • 27.CROs - Year-over-year growth 2019-2024 (%)
  • 28. Market opportunity by End user
  • 29.Customer landscape
  • 30.Market share by geography 2019-2024 (%)
  • 31.Geographic comparison
  • 32.North America - Market size and forecast 2019-2024 ($ million)
  • 33.North America - Year-over-year growth 2019-2024 (%)
  • 34.Europe - Market size and forecast 2019-2024 ($ million)
  • 35.Europe - Year-over-year growth 2019-2024 (%)
  • 36.APAC - Market size and forecast 2019-2024 ($ million)
  • 37.APAC - Year-over-year growth 2019-2024 (%)
  • 38.South America - Market size and forecast 2019-2024 ($ million)
  • 39.South America - Year-over-year growth 2019-2024 (%)
  • 40.MEA - Market size and forecast 2019-2024 ($ million)
  • 41.MEA - Year-over-year growth 2019-2024 (%)
  • 42.Key leading countries
  • 43.Market opportunity by geography ($ million)
  • 44.Impact of drivers
  • 45.Impact of challenges
  • 46.Landscape disruption
  • 47.Industry risks
  • 48.Vendors covered
  • 49.Market positioning of vendors
  • 50.Boston Analytical - Overview (1/3)
  • 51.Boston Analytical - Overview (2/3)
  • 52.Boston Analytical - Overview (3/3)
  • 53.Boston Analytical - Product and service
  • 54.Boston Analytical - Key offerings
  • 55.Boston Analytical - Key customers
  • 56.Boston Analytical - Segment focus
  • 57.Catalent Inc. - Overview (1/3)
  • 58.Catalent Inc. - Overview (2/3)
  • 59.Catalent Inc. - Overview (3/3)
  • 60.Catalent Inc. - Business segments
  • 61.Catalent Inc. - Key offerings
  • 62.Catalent Inc. - Key customers
  • 63.Catalent Inc. - Segment focus
  • 64.Charles River Laboratories International Inc. - Overview (1/3)
  • 65.Charles River Laboratories International Inc. - Overview (2/3)
  • 66.Charles River Laboratories International Inc. - Overview (3/3)
  • 67.Charles River Laboratories International Inc. - Business segments
  • 68.Charles River Laboratories International Inc. - Key offerings
  • 69.Charles River Laboratories International Inc. - Key customers
  • 70.Charles River Laboratories International Inc. - Segment focus
  • 71.Eurofins Scientific - Overview (1/3)
  • 72.Eurofins Scientific - Overview (2/3)
  • 73.Eurofins Scientific - Overview (3/3)
  • 74.Eurofins Scientific - Business segments
  • 75.Eurofins Scientific - Key offerings
  • 76.Eurofins Scientific - Key customers
  • 77.Eurofins Scientific - Segment focus
  • 78.Intertek Group PLC - Overview (1/3)
  • 79.Intertek Group PLC - Overview (2/3)
  • 80.Intertek Group PLC - Overview (3/3)
  • 81.Intertek Group PLC - Product and service
  • 82.Intertek Group PLC - Key offerings
  • 83.Intertek Group PLC - Key customers
  • 84.Intertek Group PLC - Segment focus
  • 85.Merck KGaA - Overview (1/3)
  • 86.Merck KGaA - Overview (2/3)
  • 87.Merck KGaA - Overview (3/3)
  • 88.Merck KGaA - Business segments
  • 89.Merck KGaA - Key offerings
  • 90.Merck KGaA - Key customers
  • 91.Merck KGaA - Segment focus
  • 92.SGS SA - Overview (1/3)
  • 93.SGS SA - Overview (2/3)
  • 94.SGS SA - Overview (3/3)
  • 95.SGS SA - Business segments
  • 96.SGS SA - Key offerings
  • 97.SGS SA - Key customers
  • 98.SGS SA - Segment focus
  • 99.Solvias AG - Overview (1/3)
  • 100.Solvias AG - Overview (2/3)
  • 101.Solvias AG - Overview (3/3)
  • 102.Solvias AG - Business segments
  • 103.Solvias AG - Key offerings
  • 104.Solvias AG - Key customers
  • 105.Solvias AG - Segment focus
  • 106.STERIS Plc - Overview (1/3)
  • 107.STERIS Plc - Overview (2/3)
  • 108.STERIS Plc - Overview (3/3)
  • 109.STERIS Plc - Business segments
  • 110.STERIS Plc - Key offerings
  • 111.STERIS Plc - Key customers
  • 112.STERIS Plc - Segment focus
  • 113.West Pharmaceutical Services Inc. - Overview (1/3)
  • 114.West Pharmaceutical Services Inc. - Overview (2/3)
  • 115.West Pharmaceutical Services Inc. - Overview (3/3)
  • 116.West Pharmaceutical Services Inc. - Product and service
  • 117.West Pharmaceutical Services Inc. - Key offerings
  • 118.West Pharmaceutical Services Inc. - Key customers
  • 119.West Pharmaceutical Services Inc. - Segment focus
  • 120.Currency conversion rates for US$
  • 121.Research Methodology
  • 122.Validation techniques employed for market sizing
  • 123.Information sources
  • 124.List of abbreviations
Back to Top
전화 문의
F A Q